Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 211 publications
Progression-Free Survival in Metastatic Breast Cancer by Local Investigators vs Blinded Independent Central Review: A Systematic Review and Meta-Analysis.
Journal: JAMA oncology
Published: July 16, 2026
Breast Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: July 09, 2026
Now or later? Switching therapies in metastatic breast cancer.
Journal: The Lancet. Oncology
Published: June 22, 2026
Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 16, 2026
Corrigendum to 'Long-term outcomes with adjuvant CDK4/6 inhibitors: who benefits most?': [Annals of Oncology. Volume 37, Issue 2, February 2026, Pages 133-135].
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 08, 2026
SACI-IO HR+: a randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 20, 2026
SACI-IO HR+: A randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 20, 2026
NCCN Guidelines® Insights: Breast Cancer, Version 5.2025.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: November 10, 2025
Long-term outcomes with adjuvant CDK4/6 inhibitors: who benefits most?
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 06, 2025
Outcomes of patients with de novo oligometastatic breast cancer treated with curative intent at a single institution.
Journal: Breast cancer research and treatment
Published: September 10, 2025
Tailoring treatment to cancer risk and patient preference: the 2025 St Gallen International Breast Cancer Consensus Statement on individualizing therapy for patients with early breast cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: August 06, 2025
Last Updated: 09/26/2026